MULTI-CANCER, MULTI-DISEASE, EARLY DETECTION TESTS USING A URINE SAMPLE
Please register and contact us if interested
1) To use our MinION enabled microRNA quantification services and solutions.
2) To participate remotely in a future IRB-approved study and provide your urine sample
for microRNA evaluation.
3) To collaborate in a grant application to implement and evaluate the Yenos microRNA
test in your facilities.
4) To use our consulting services in facilitating HPLC purity evaluation of your in-house
made mRNA batches.
Why is Early Detection Important?
![Yenos Analytical A person holding two test tubes in their hands.](https://yenosanalytical.com/wp-content/uploads/2024/02/img1.png)
All men are at risk for prostate cancer. Out of every 100 American men, about 13 will get prostate cancer during their lifetime, and about 2 to 3 men will die from it.
![Yenos Analytical A person in blue gloves holding a yellow object.](https://yenosanalytical.com/wp-content/uploads/2024/02/img2.png)
About 5-10% of pancreatic cancer patients survive past five years after diagnosis, and those with stage 4 pancreatic cancer have a five-year survival rate of 1%.
![Yenos Analytical A woman in lab coat and gloves working on a device.](https://yenosanalytical.com/wp-content/uploads/2024/02/img3.png)
Screening mammograms miss about 1 in 8 breast cancers. After 10 yearly mammograms, the chance of having at least one false positive result is about 50%.
![Yenos Analytical A person holding a test tube in their hands.](https://yenosanalytical.com/wp-content/uploads/2024/02/f1d1fd2.png)
Multi-Cancer, Multi-Disease Screening
Yenos Analytical
How It Works
Yenos Analytical
![Yenos Analytical A purple and white rack with many cups of liquid.](https://yenosanalytical.com/wp-content/uploads/2024/02/img4.png)